Dr Ryan Cawood
Founder & Chief Executive Officer
Ryan founded the company in 2011 with the aim to revolutionise DNA design, optimisation and assembly to enable molecular engineering to fulfil its promise in synthetic biology and medicine. He is an experienced genetic engineer with extensive knowledge and practical insight working with bacterial, botanical and mammalian recombinant expression systems.
Chief Operating Officer
Jocelyne has an extensive background working in businesses from science and engineering technology sectors. Prior to joining OXGENE she was Chief Revenue Officer at EYOTO, where she determined product strategy and was responsible for a complete rebrand of the organisation as well as building a sales and marketing team.
Chief Financial Officer
Martin joined the company in November 2017 and has more than 30 years financial and general management experience in technology and IP-focused businesses. He specialises in leading and developing small technology organisations through periods of rapid growth, fund-raising and international expansion to exit events including trade sale or preparation for IPO.
Chief Commercial Officer
Charles has a 20 year track record of delivering large scale programmes & performance improvement across many of the world’s most well-known industrial, financial & government entities. He’s previously held senior management and consulting roles within organisations including ABB, Tetra Pak, GE/Alstom, BAE Systems, Barclays and several local government authorities.